This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Genetic Technologies Ltd (GENE)

NASDAQ: Services

Company Cash Flow
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Cash Flow From Operating Activities
Net Income (Loss) -9.54M -8.68M -5.42M 963.32K
Operating Gains/Losses 182.50K 405.49K -5.28M 305.45K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -737.12K 155.27K 182.69K 85.81K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 194.27K -178.00K -15.17K 0.00
(Decrease) Increase In Payables 69.34K 435.89K -214.30K -86.19K
(Decrease) Increase In Other Current Liabilities -221.81K 14.83K 0.00 -33.02K
(Increase) Decrease In Other Working Capital -748.99K 50.23K 194.72K 44.67K
Other Non-Cash Items 156.17K 319.28K 2.18M 558.81K
Net Cash From Continuing Operations -10.34M -6.97M -7.86M 2.39M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -10.34M -6.97M -7.86M 2.39M
Sale of Property, Plant & Equipment 0.00 1.11K 32.21K 154.66K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -45.11K -49.74K -78.15K -149.28K
Acquisitions 0.00 -117.14K 10.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -172.34K 0.00 549.97K 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 218.78K -165.77K 504.04K 5.38K
Issuance of Debt 5.25M 0.00 1.02M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 6.59M 446.78K 11.16M 0.00
Repayment of Long-Term Debt 0.00 -16.47K -1.08M -336.41K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -619.97K -23.94K 0.00 0.00
Net Cash From Financing Activities 11.23M 406.38K 11.11M -336.41K
Effect of Exchange Rate Changes -55.04K 72.87K 129.54K -133.80K
Net Change in Cash & Cash Equivalents 1.04M -6.66M 3.89M 1.92M

GENE Genetic Technologies Ltd

Chart of GENE

Analysts Ratings for GENE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

GENE Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs